---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-22-011496"
form_type: "8-K"
ticker: "TNYA"
cik: "0001858848"
company_name: "Tenaya Therapeutics, Inc."
filed_at: "2022-06-10T23:59:59+00:00"
generated_at: "2026-06-25T02:55:25.981973+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.4
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# Tenaya Therapeutics reports stockholder votes from 2022 annual meeting

## Summary
- Four Class I directors elected: David Goeddel (34,063,079 for), Karah Parschauer (34,833,578), Jeffrey Walsh (34,112,810), R. Sanders Williams (34,135,556); 829,857 broker non-votes each.
- Ratification of Deloitte & Touche as independent auditor for FY2022: 35,984,423 for, 148 against, 244 abstain; no broker non-votes.
- All director nominees will serve until the 2025 annual meeting or until successors are elected.

## SEC filing metadata
- accession: 0000950170-22-011496
- form_type: 8-K
- ticker: TNYA
- cik: 0001858848
- company_name: Tenaya Therapeutics, Inc.
- filed_at: 2022-06-10T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.4
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1858848/000095017022011496/0000950170-22-011496-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1858848/000095017022011496/tnya-20220609.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-22-011496
- JSON: https://secwatch.observer/filing/0000950170-22-011496.json
- Plain text: https://secwatch.observer/filing/0000950170-22-011496.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.